- Home
- ARCT vs GRAL Comparison
ARCT vs GRAL Comparison
Compare ARCT & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- GRAL
- Stock Information
- Founded
- ARCT 2013
- GRAL 2016
- Country
- ARCT United States
- GRAL United States
- Employees
- ARCT N/A
- GRAL N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- GRAL
- Sector
- ARCT Health Care
- GRAL
- Exchange
- ARCT Nasdaq
- GRAL NYSE
- Market Cap
- ARCT 487.0M
- GRAL 610.9M
- IPO Year
- ARCT N/A
- GRAL N/A
- Fundamental
- Price
- ARCT $15.88
- GRAL $27.78
- Analyst Decision
- ARCT Strong Buy
- GRAL Hold
- Analyst Count
- ARCT 8
- GRAL 2
- Target Price
- ARCT $61.00
- GRAL $16.00
- AVG Volume (30 Days)
- ARCT 405.9K
- GRAL 1.1M
- Earning Date
- ARCT 03-06-2025
- GRAL 02-15-2025
- Dividend Yield
- ARCT N/A
- GRAL N/A
- EPS Growth
- ARCT N/A
- GRAL N/A
- EPS
- ARCT N/A
- GRAL N/A
- Revenue
- ARCT $160,399,000.00
- GRAL $117,669,000.00
- Revenue This Year
- ARCT $7.33
- GRAL $32.48
- Revenue Next Year
- ARCT $4.71
- GRAL $14.72
- P/E Ratio
- ARCT N/A
- GRAL N/A
- Revenue Growth
- ARCT N/A
- GRAL 111.83
- 52 Week Low
- ARCT $14.30
- GRAL $12.33
- 52 Week High
- ARCT $45.00
- GRAL $32.65
- Technical
- Relative Strength Index (RSI)
- ARCT 41.74
- GRAL N/A
- Support Level
- ARCT $16.03
- GRAL N/A
- Resistance Level
- ARCT $17.95
- GRAL N/A
- Average True Range (ATR)
- ARCT 1.29
- GRAL 0.00
- MACD
- ARCT -0.07
- GRAL 0.00
- Stochastic Oscillator
- ARCT 10.29
- GRAL 0.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.